Jespersen J
Gynecol Obstet Invest. 1983;15(5):266-74. doi: 10.1159/000299420.
Determinations of plasma euglobulin fibrinolytic activity were made in samples of plasma collected during one normal or hormone-simulated cycle in 15 young, normal women and in 11 women using an oral contraceptive low in estrogen. Distinct, individual levels caused the variations of fibrinolytic activity to be larger within the group than individually, and the activity showed only small changes during the cycle. The hormone group showed a marked increase in fibrinolytic activity with distinct fluctuations related to the phase of the cycle. This increase corresponded to that previously reported to be caused by oral contraceptives containing higher concentrations of estrogen.
对15名年轻健康女性在一个正常或激素模拟周期内采集的血浆样本,以及11名使用低雌激素口服避孕药的女性的血浆样本,进行了血浆优球蛋白纤溶活性测定。个体水平差异明显,导致组内纤溶活性的变化大于个体间的变化,且该活性在周期内仅表现出微小变化。激素组纤溶活性显著增加,且与周期阶段相关存在明显波动。这种增加与先前报道的由含较高浓度雌激素的口服避孕药引起的增加相一致。